Promising brain cancer trial for kids withdrawn before it began

NCT ID NCT04482933

First seen Nov 01, 2025 · Last updated Jun 17, 2026 · Updated 34 times

Summary

This study aimed to test an experimental virus therapy (G207) injected directly into the brain tumor, combined with a single dose of radiation, in children whose high-grade glioma had come back after prior treatment. The goal was to see if the treatment could help children live longer. However, the study was withdrawn before any participants were enrolled, so no results are available.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIGH-GRADE GLIOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Holly Lindsay MD

    Aurora, Colorado, 80045, United States

  • MD Anderson Cancer Center

    Houston, Texas, 77030, United States

  • Memorial Sloan Kettering

    New York, New York, 14263, United States

  • Texas Children's Hospital

    Houston, Texas, 77030, United States

  • UPMC Children's Hospital of Pittsburgh

    Pittsburgh, Pennsylvania, 15224, United States

Conditions

Explore the condition pages connected to this study.